Loading...

Vycor Medical, Inc.

VYCOPNK
Healthcare
Medical - Devices
$0.13
$0.03(30.00%)

Vycor Medical, Inc. (VYCO) Company Profile & Overview

Explore Vycor Medical, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Vycor Medical, Inc. (VYCO) Company Profile & Overview

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates in two segments, Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. Vycor Medical, Inc. has a license and transition agreement with HelferApp GmbH, which grants HelferApp the license to provide NovaVision's products and therapies to patients and professionals in Austria and Switzerland. The company primarily serves hospitals and medical professionals. Vycor Medical, Inc. was incorporated in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited.

SectorHealthcare
IndustryMedical - Devices
CEOPeter C. Zachariou

Contact Information

561 558 2000
951 Broken Sound Boulevard, Boca Raton, FL, 33487

Company Facts

7 Employees
IPO DateJan 16, 2013
CountryUS
Actively Trading

Frequently Asked Questions

;